ADMA — ADMA BIOLOGICS INC

Ownership history in XTX Topco Ltd · 12 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.17% (2023 Q4)

Avg. % of fund

0.04%

First filed

2021 Q2

Last filed

2025 Q3

Quarters held

12

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	ADDED	86,503	+74,430	+616.5%	0.07%	$1.3M	$14.66
2025 Q1	REDUCED	12,073	-11,034	-47.8%	0.01%	$240K	$19.84
2024 Q4	REDUCED	23,107	-83,734	-78.4%	0.03%	$396K	$17.15
2024 Q1	REDUCED	106,841	-62,232	-36.8%	0.10%	$705K	$6.60

% of Fund (quarterly) ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%

← Back to XTX Topco Ltd Holdings